OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+15.95%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$41.9M
AUM Growth
+$41.9M
(-9.2%)
Cap. Flow
-$8.75M
Cap. Flow
% of AUM
-20.88%
Top 10 Holdings %
Top 10 Hldgs %
48.42%
Holding
52
New
2
Increased
17
Reduced
26
Closed
5
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$3.23M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.04M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$1.14M |
| 4 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$591K |
| 5 |
Fortress Biotech
FBIO
|
$374K |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$5.52M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$5.37M |
| 3 |
iShares Biotechnology ETF
IBB
|
$2.06M |
| 4 |
Biogen
BIIB
|
$884K |
| 5 |
Amgen
AMGN
|
$848K |
Sector Composition
| 1 | Healthcare | 97.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
-58,000
| Closed | -$5.52M |
|
|
52
ProShares Ultra NASDAQ Biotechnology
BIB
$55.7M
| – | – |
-93,805
| Closed | -$5.37M |
|